Results 201 to 210 of about 36,160 (268)

Immunogenicity of yellow fever vaccine co-administered with 13-valent pneumococcal conjugate vaccine in rural Gambia: A cluster-randomised trial. [PDF]

Vaccine
Osei I, Schmidt-Chanasit J, Licciardi PV, Secka O, D'Alessandro U, Salaudeen R, Sarwar G, Clarke E, Mohammed NI, Nguyen C, Greenwood B, Jansen S, Mackenzie GA.   +12 more
europepmc   +1 more source

ASSESSMENT OF TOLERABILITY OF PNEUMOCOCCAL CONJUGATE VACCINE AND THE INFLUENCE OF THE VACCINATION ON THE INCIDENCE OF RESPIRATORY INFECTIONS IN CHILDREN DURING THE FIRST FIVE YEARS OF LIFE IN THE SAKHA REPUBLIC (YAKUTIA)

, 2011
N.V. Savvina, V.B. Egorova
openalex   +1 more source

Cost-Effectiveness Analysis of the Use of V116, a 21-Valent Pneumococcal Conjugate Vaccine, in Vaccine-Naïve Adults Aged ≥ 65 Years in the United States. [PDF]

Infect Dis Ther
Yi Z, Owusu-Edusei K, Elbasha E.
europepmc   +1 more source

Immunogenicity of DTaP-IPV-Hib and MenC vaccines in the UK when administered with a 13-valent pneumococcal conjugate vaccine

, 2008
Baker, S., Daniels, E., Dymond, S., Faust, S.N., Finn, A., Galiza, E., Gruber, W., Heath, P.T., John, T., Klinger, C., Layton, H., Pestridge, S., Pollard, A., Scott, D., Snape, M., Tansey, S.   +15 more
core